SAN RAFAEL, Calif., Oct. 10, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, October 26, at 4:30 p.m. ET to discuss third quarter 2017 financial results and provide a general business update.

Dial-in Number
U.S. / Canada Dial-in Number: (866) 502-9859
International Dial-in Number: (574) 990-1362
Conference ID: 96054850

Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 96054850

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. 



    Contacts:


    Investors                    Media

    Traci McCarty                Debra Charlesworth

    BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc.

    (415) 455-7558               (415) 455-7451

View original content with multimedia:http://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2017-financial-results-conference-call-and-webcast-on-thursday-october-26-at-430-pm-et-300533536.html

SOURCE BioMarin Pharmaceutical Inc.